Listen to this 20-minute on-demand webinar or read the executive summary to learn about:
• New front-line evidence based on bronchoscopies performed on COVID-19
• The risks bronchoscopy reprocessing personnel face due to potential exposure to contaminated bronchoscopes
• Recommendations for how to protect both patients and staff
Risks and best practices for bronchoscope use on COVID-19 patients
Ofstead & Associates
“Given the high bronchoscope contamination rates found during routine use in previous studies, we must now consider the possibility of bronchoscopy-associated transmission of COVID-19 or other pathogens that could cause secondary infections.”
Cori Ofstead Et al.1
Cori Ofstead, President and CEO at Ofstead & Associates, Inc.
Cori Ofstead, an epidemiologist with 25 years of research experience, leads a multidisciplinary team that specialises in designing and conducting real-world studies to validate healthcare guidelines, treatments, and product claims.
 Ofstead, C., Hopkins, K., Binnicker, M., & Poland, G. (n.d.). Potential impact of contaminated bronchoscopes on novel coronavirus disease (COVID-19) patients. Infection Control & Hospital Epidemiology, 1-10. doi:10.1017/ice.2020.102